Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Justin87
    Junior Member
    • Jan 2017
    • 6

    #1

    Reason for POOR per tile sequence quality

    We recently performed a sequencing run on the MiSeq sequencer using a V3 (600 cycle kit).

    With regards to the per tile quality plot (obtained when using the FastQC analysis software) for one of our samples, it seems as though there is a large area that is flagged in red for R2, indicating that those tiles had worse qualities.

    I was just wondering on possible reasons why this would happen and how it could be prevented in future runs?

    Thanks!
    Attached Files
  • Markiyan
    Senior Member
    • Sep 2010
    • 126

    #2
    Looks like there is a problem with imaging one of the flowcell surfaces...

    It looks like there is a problem with imaging one of the flowcell surfaces...

    Either focusing issue (Z axis lens mover in a need of some cleaning/re greasing/calibration) or lots of very small bubbles (if it is an upper surface) (but then they would affect the other surface with such width.

    Also check tile thumbnail images, and contact illumina if this instrument is on service contract.

    You can also try making movie from thumbnail jpg images using image magic and some scripting...

    Comment

    • GW_OK
      Senior Member
      • Sep 2009
      • 411

      #3
      2xxx tiles are on the bottom surface. I concur with the possibilities raised by Markiyan. Looks like it started somewhere around cycle 35. Definitely a call to tech support is in order.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-11-2026, 10:35 AM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...